Sustainability Focus Novo Nordisk is actively pursuing process innovations to reduce water usage through membrane purification for pharmaceutical wastewater, aiming to cut freshwater consumption by about half. This signals an opportunity to position sustainability partnerships, environmental compliance solutions, and cost-saving collaborations around green manufacturing and circular water programs.

Expansion and capex Upcoming facility expansions in Denmark and Northern Europe with potential full-scale purification plant at Hillerød indicate a growing manufacturing footprint. Sales opportunities exist in process automation, facility modernization, equipment upgrades, and data integration for expanded sites.

Regulatory readiness As a heavily regulated pharmaceutical manufacturer with significant restructuring history, Novo Nordisk prioritizes quality systems and compliance leadership. This creates demand for governance, audit readiness, quality intelligence analytics, and risk management solutions to support regulatory obligations.

Technology stack Largely leveraging analytics and cloud platforms including Adobe Analytics, Looker, Power BI, Google Cloud, and Fortinet, they value data-driven decision making and secure IT environments. There is a clear opportunity to offer end-to-end data integration, advanced analytics, cloud optimization, and cybersecurity services aligned with their tech stack.

Strategic partnerships Recent partnerships and collaborations in patient support, membrane purification, and supplier ecosystem (e.g., Clever Culture Systems, smartpatient) show openness to external alliances. This opens doors for joint programs in patient engagement, digital health solutions, and back-end process improvements across manufacturing and supply chains.